Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites

Sponsor
University Hospital Ostrava (Other)
Overall Status
Recruiting
CT.gov ID
NCT04900740
Collaborator
(none)
250
1
2
42.9
5.8

Study Details

Study Description

Brief Summary

The study will evaluate a new type of cyanoacrylate tissue glue Secure PortIV on the insertion site of the PICC (Peripherally inserted central catheter) or Midline catheters. Fixation of the catheter with the tissue glue should prevent incidents of mechanical and infective phlebitis as well as external migrations of the catheters.

Condition or Disease Intervention/Treatment Phase
  • Device: Catheter fixation with surgical stitch
  • Device: Catheter fixation with glue (cyanoacrylate tissue glue Secure PortIV)
N/A

Detailed Description

In the study, 125 subjects will receive the new tissue glue Secure PortIV and 125 subjects will be provided standard care. The tissue glue will be applied immediately after insertion. Evaluation and re-evaluation of the site will be done on the first and seventh day after insertion using VIP and CLISA (Central-Line Insertion Site Assessment) scale and on the seventh day with taking a swab from the insertion site; the external length will be measured on the first and the seventh day, in order to observe the migration or not.

The goal of the study is to evaluate the benefits of the cyanoacrylate tissue glue Secure PortIV in the prevention of mechanical and infective phlebitis and external migration of the catheter.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The patients will be enrolled into one of two study groups, depending on the decision of the attending physician.The patients will be enrolled into one of two study groups, depending on the decision of the attending physician.
Masking:
None (Open Label)
Masking Description:
No masking will be used in the study.
Primary Purpose:
Other
Official Title:
Evaluation of a Tissue Glue SecurePortIV on Prevention of Phlebitis and Migration of PICC and Midline Catheters in Adult Patients
Actual Study Start Date :
May 4, 2021
Anticipated Primary Completion Date :
Jan 1, 2022
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard care - catheter fixation with surgical stitch

In patients indicated for this type of treatment, as per the attending physician, the catheter will be fixed in the standard way, using a surgical stitch.

Device: Catheter fixation with surgical stitch
The catheter will be fixed using the standard procedure - surgical stitch.

Experimental: Experimental - catheter fixation with glue

In patients indicated for this type of treatment, as per the attending physician, the catheter will be fixed using the glue.

Device: Catheter fixation with glue (cyanoacrylate tissue glue Secure PortIV)
The catheter will be fixed using the experimental procedure - novel surgical glue.

Outcome Measures

Primary Outcome Measures

  1. The incidence of mechanical and infective phlebitis [Up to 6 months]

    The incidence of mechanical and infective phlebitis will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment

Secondary Outcome Measures

  1. The incidence of external migration of the catheter [Up to 6 months]

    The incidence of external migration of the catheter will be measured in the group with the cyanoacrylate tissue glue in comparison with the standard treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years of age

  • need of long-term venous access

  • consent with participation in the study

Exclusion Criteria:
  • pediatric population

  • not signing the informed consent form

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Ostrava Ostrava Moravian-Silesian Region Czechia 708 52

Sponsors and Collaborators

  • University Hospital Ostrava

Investigators

  • Principal Investigator: Iveta Constantine, Bc., MSc., University Hospital Ostrava

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital Ostrava
ClinicalTrials.gov Identifier:
NCT04900740
Other Study ID Numbers:
  • FNO-PICC-03
  • 03/RVO-FNOs/2021
First Posted:
May 25, 2021
Last Update Posted:
Jun 1, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital Ostrava
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2021